TANTUCCI, Michela
 Distribuzione geografica
Continente #
NA - Nord America 636
EU - Europa 450
AS - Asia 198
SA - Sud America 1
Totale 1.285
Nazione #
US - Stati Uniti d'America 634
IT - Italia 117
IE - Irlanda 114
CN - Cina 50
SG - Singapore 50
SE - Svezia 45
HK - Hong Kong 44
FR - Francia 43
VN - Vietnam 35
FI - Finlandia 24
UA - Ucraina 23
DE - Germania 21
RU - Federazione Russa 16
GB - Regno Unito 15
RO - Romania 14
KR - Corea 10
CZ - Repubblica Ceca 6
TR - Turchia 6
BE - Belgio 3
MX - Messico 2
NL - Olanda 2
PL - Polonia 2
RS - Serbia 2
AT - Austria 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
IR - Iran 1
JP - Giappone 1
LB - Libano 1
Totale 1.285
Città #
Chandler 192
Dublin 114
Perugia 57
San Mateo 47
Hong Kong 44
Boardman 38
Singapore 36
Dong Ket 35
Altamura 30
Santa Clara 29
Ann Arbor 28
Beijing 26
Medford 23
Princeton 23
Lawrence 21
Wilmington 20
Andover 16
Redmond 16
Des Moines 15
Bucharest 12
Jacksonville 10
Seoul 10
Munich 7
Woodbridge 7
Izmir 6
Dallas 4
Helsinki 4
Los Angeles 4
Norwalk 4
Pomezia 4
San Paolo di Civitate 4
Ashburn 3
Brno 3
Brussels 3
Moscow 3
Prato 3
Redwood City 3
Saint Petersburg 3
Terni 3
Espoo 2
Olomouc 2
Timisoara 2
Utrecht 2
Auburn Hills 1
Cambridge 1
Derio 1
Frankfurt am Main 1
Ludwigshafen am Rhein 1
Monterrey 1
Nagold 1
Parma 1
Pars 1
Rome 1
Shanghai 1
Sovicille 1
Tappahannock 1
Tokyo 1
Totale 932
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 151
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 86
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 81
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 73
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 63
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 63
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 60
Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression 60
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 57
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 57
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 55
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 54
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 54
Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neoformans strain. 52
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 50
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 48
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease 48
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice. 47
Relazione tra effetti precoci e tardivi dell' ischemia cerebrale nel gerbillo. 43
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 43
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 37
Mortalin Inhibition in Experimental Parkinson's Disease 35
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 31
Stabilità delle tracce di memoria in ratti Wistar durante l'invecchiamento 26
Totale 1.374
Categoria #
all - tutte 5.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 5 3 6 11 7 25 2 5
2020/2021159 1 3 8 8 47 10 4 11 15 6 7 39
2021/2022229 4 30 7 8 5 1 2 64 7 32 38 31
2022/2023481 24 94 4 72 35 57 0 26 153 1 10 5
2023/2024153 8 17 7 1 1 0 42 0 5 2 40 30
2024/2025107 9 30 21 11 36 0 0 0 0 0 0 0
Totale 1.374